CapEx at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept xers:ProceedsPaymentsFromCapitalExpenditures.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s capex?
- Xeris Biopharma Holdings, Inc. (XERS) reported capex of -$325K in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s capex changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s capex decreased by 2400.0% year-over-year, from -$13K to -$325K.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s capex?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s capex has grown at a -10.5% compound annual growth rate (CAGR), from -$1.09M to -$696K.
- What does capex mean?
- This measures the cash outflows for the acquisition of property, plant, equipment, and other long-term assets. It represents the company's investment in its infrastructure and capacity to support future growth. High levels of capital expenditure indicate a focus on scaling operations or maintaining technological competitiveness.